<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Martinez-Rubio D</submitter><funding>Spanish Ministry of Science and Innovation</funding><funding>Spanish Ministry of Economy and Competitiveness</funding><funding>Fundació la Marató de TV3</funding><funding>Generalitat Valenciana</funding><funding>European Regional Development Fund</funding><pagination>3897-3913</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9652108</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>31(22)</volume><pubmed_abstract>Peroxiredoxin 3 (PRDX3) encodes a mitochondrial antioxidant protein, which is essential for the control of reactive oxygen species homeostasis. So far, PRDX3 mutations are involved in mild-to-moderate progressive juvenile onset cerebellar ataxia. We aimed to unravel the molecular bases underlying the disease in an infant suffering from cerebellar ataxia that started at 19 months old and presented severe cerebellar atrophy and peripheral neuropathy early in the course of disease. By whole exome sequencing, we identified a novel homozygous mutation, PRDX3 p.D163E, which impaired the mitochondrial ROS defense system. In mouse primary cortical neurons, the exogenous expression of PRDX3 p.D163E was reduced and triggered alterations in neurite morphology and in mitochondria. Mitochondrial comput</pubmed_abstract><journal>Human molecular genetics</journal><pubmed_title>Protein misfolding and clearance in the pathogenesis of a new infantile onset ataxia caused by mutations in PRDX3.</pubmed_title><pmcid>PMC9652108</pmcid><funding_grant_id>20143130</funding_grant_id><funding_grant_id>20143131</funding_grant_id><funding_grant_id>PI18/00147</funding_grant_id><funding_grant_id>PRE2018-083562</funding_grant_id><funding_grant_id>RyC-2014-16410</funding_grant_id><funding_grant_id>PI21/00103</funding_grant_id><funding_grant_id>SAF2017-89020-R</funding_grant_id><funding_grant_id>PROMETEO/2018/135</funding_grant_id><pubmed_authors>Navarro-Gonzalez C</pubmed_authors><pubmed_authors>Martinez-Rubio D</pubmed_authors><pubmed_authors>Gorria-Redondo N</pubmed_authors><pubmed_authors>Jenkins A</pubmed_authors><pubmed_authors>Rodriguez-Prieto A</pubmed_authors><pubmed_authors>Espinos C</pubmed_authors><pubmed_authors>Sancho P</pubmed_authors><pubmed_authors>Fazzari P</pubmed_authors><pubmed_authors>Aguilera-Albesa S</pubmed_authors><pubmed_authors>Perez-Duenas B</pubmed_authors><pubmed_authors>Marco-Marin C</pubmed_authors><pubmed_authors>Miquel-Leal J</pubmed_authors><pubmed_authors>Soriano-Navarro M</pubmed_authors><pubmed_authors>Hernandez A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Protein misfolding and clearance in the pathogenesis of a new infantile onset ataxia caused by mutations in PRDX3.</name><description>Peroxiredoxin 3 (PRDX3) encodes a mitochondrial antioxidant protein, which is essential for the control of reactive oxygen species homeostasis. So far, PRDX3 mutations are involved in mild-to-moderate progressive juvenile onset cerebellar ataxia. We aimed to unravel the molecular bases underlying the disease in an infant suffering from cerebellar ataxia that started at 19 months old and presented severe cerebellar atrophy and peripheral neuropathy early in the course of disease. By whole exome sequencing, we identified a novel homozygous mutation, PRDX3 p.D163E, which impaired the mitochondrial ROS defense system. In mouse primary cortical neurons, the exogenous expression of PRDX3 p.D163E was reduced and triggered alterations in neurite morphology and in mitochondria. Mitochondrial comput</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2026-05-28T00:32:54.189Z</modification><creation>2025-04-06T01:50:46.705Z</creation></dates><accession>S-EPMC9652108</accession><cross_references><pubmed>35766882</pubmed><doi>10.1093/hmg/ddac146</doi></cross_references></HashMap>